Correction to: Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants (Protein & Cell, (2018), 9, 9, (814-819), 10.1007/s13238-018-0568-x);Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants

Protein and Cell

Volumn 9, Issue 9, 2018, Pages 814-819

  Yang, Lei ^a   Zhang, Xiaohui ^a   Wang, Liren ^a   Yin, Shuming ^a   Zhu, Biyun ^a   Xie, Ling ^a   Duan, Qiuhui ^a   Hu, Huiqiong ^a,b   Zheng, Rui ^c   Wei, Yu ^a   Peng, Liangyue ^a,d   Han, Honghui ^e   Zhang, Jiqin ^a   Qiu, Wenjuan ^c   Geng, Hongquan ^c   Siwko, Stefan ^f   Zhang, Xueli ^a,b   Liu, Mingyao ^a,f   Li, Dali ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d HUNAN NORMAL UNIVERSITY   (China)

^e Bioray Laboratories Inc   (China)

^f TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; FUMARYLACETOACETASE; GENOMIC DNA; ADENOSINE;

ANIMAL TISSUE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR-CAS9 SYSTEM; DNA CLEAVAGE; DNA END JOINING REPAIR; DNA MODIFICATION; EMBRYO; ENZYME ACTIVITY; GENE EDITING; GENE FREQUENCY; IMMUNOHISTOCHEMISTRY; LETTER; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA STABILITY; SANGER SEQUENCING; STOP CODON; ANIMAL; C57BL MOUSE; CRISPR CAS SYSTEM; GENETIC VARIATION; GENETICS; MAMMALIAN EMBRYO; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CRISPR-ASSOCIATED PROTEIN 9; CRISPR-CAS SYSTEMS; EMBRYO, MAMMALIAN; GENE EDITING; GENETIC VARIATION; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85051131141     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-019-0631-2     Document Type: Erratum

References (15)

1. Frischmeyer PA, van Hoof A, O’Donnell K, Guerrerio AL, Parker R, Dietz HC (2002) An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 295:2258–2261. 10.1126/science.1067338
2. Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551:464–471. 10.1038/nature24644
3. Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB et al (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33:985–989. 10.1038/nbt.3290
4. Keeling KM, Xue X, Gunn G, Bedwell DM (2014) Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet 15:371–394. 10.1146/annurev-genom-091212-153527
5. Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK (2015a) Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol 33:1293–1298. 10.1038/nbt.3404
6. Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales APW, Li Z, Peterson RT, Yeh J-RJ et al (2015b) Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523:481–485. 10.1038/nature14592
7. Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420–424. 10.1038/nature17946
8. Kroos MA, Kirschner J, Gellerich FN, Hermans MMP, Van der Ploeg AT, Reuser AJJ, Korinthenberg R (2004) A case of childhood Pompe disease demonstrating phenotypic variability of p.Asp645Asn. Neuromuscul Disord 14:371–374. 10.1016/j.nmd.2004.02.012
9. Li X, Wang Y, Liu Y, Yang B, Wang X, Wei J, Lu Z, Zhang Y, Wu J, Huang X et al (2018) Base editing with a Cpf1-cytidine deaminase fusion. Nat Biotechnol 36:324–327. 10.1038/nbt.4102
10. Liu Z, Lu Z, Yang G, Yang G, Li G, Feng S, Liu Y, Li J, Yu W, Zhang Y et al (2018) Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing. Nat Commun 9:2338. 10.1038/s41467-018-04768-7
11. Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY et al (2016) Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. 10.1126/science.aaf8729
12. Ryu S-M, Koo T, Kim K, Lim K, Baek G, Kim S-T, Kim HS, Kim D, Lee H, Chung E et al (2017) Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat Biotechnol. 10.1038/nbt.4148
13. Shao Y, Wang L, Guo N, Wang S, Yang L, Li Y, Wang M, Yin S, Han H, Zeng L et al (2018) Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats. J Biol Chem. 10.1074/jbc.RA117.000347
14. Wang H, La Russa M, Qi LS (2016) CRISPR/Cas9 in genome editing and beyond. Annu Rev Biochem. 10.1146/annurev-biochem-060815-014607
15. Zhou C, Zhang M, Wei Y, Sun Y, Sun Y, Pan H, Yao N, Zhong W, Li Y, Li W et al (2017) Highly efficient base editing in human tripronuclear zygotes. Protein Cell 8(10):772–775